German stocks - Factors to watch on August 20

FRANKFURT/BERLIN Wed Aug 20, 2014 2:32am EDT

Related Topics

FRANKFURT/BERLIN Aug 20 (Reuters) - The DAX top-30 index looked set to open unchanged on Wednesday, according to premarket data from brokerage Lang & Schwarz at 0613 GMT.

The following are some of the factors that may move German stocks:

MORPHOSYS

Indicated 1.8 pct higher

Morphosys and Emergent Biosolutions signed a license agreement to co-develop and commercialize prostate cancer drug candidate ES414. Emergent will receive a $20 million upfront payment and will be eligible for potential milestone payments of up to $163 million.

Related news

STROEER

Indicated 2.9 pct higher

The outdoor advertising group said it was targeting 2014 adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) of at least 135 million euros ($180 million), more than the average estimate of 132 million euros in a Reuters poll of analysts.

Related news

SKW METALLURGIE

Indicated 1.5 pct higher

SKW's core business is healthy and the supplier to the steel industry has no liquidity problems, Handelsblatt newspaper cited Chief Executive Kay Michel as saying.

Related news

ANALYSTS' VIEWS

E.ON - Societe Generale raises to "hold" from "sell"; target price raised to 13.5 euros from 12 euros.

SIEMENS - Goldman Sachs raises its recommendation on the stock to "buy" from "neutral", lifts its target price to 118 euros from 115 euros.

OVERSEAS STOCK MARKETS

Dow Jones +0.5 pct, S&P 500 +0.5 pct, Nasdaq +0.4 pct at Tuesday's close.

Nikkei +0.03 pct at Wednesday's close.

GERMAN ECONOMIC DATA

July producer prices slipped 0.1 percent from the previous month and were down 0.8 percent from a year earlier, the Federal Statistics Office said. Economists polled by Reuters had forecast that prices would be unchanged on the month and fall by 0.7 percent year on year.

EUROPEAN FACTORS TO WATCH

DIARIES

REUTERS TOP NEWS (1 US dollar = 0.7518 euro) (Reporting by Ludwig Burger and Andreas Cremer)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.